Shasqi presented the scientific poster titled, Tumor-Selective MMAE Activation via CEACAM5 Pre-Targeting Using Click Chemistry: A First-in-Class Strategy to Enhance Clinical Benefit, on October 18, 2025 at the European Society for Medical Oncology (ESMO) Congress in Berlin, Germany.

View the abstract here.